- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (710)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (108)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (4)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (620)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (224)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (876)
- Research (384)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (596)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (324)
- Symptoms (182)
- Treatment (1762)
3 myths about anal cancer, debunked
3 minute read | Published August 21, 2023
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on August 21, 2023
Anal cancer is a fairly rare type of cancer that develops in the anus and anal canal. About 8,000 people in the U.S. are diagnosed with anal cancer each year.
If detected early, anal cancer can be treated successfully. Unfortunately, there are a lot of myths regarding anal cancer. We spoke with gastrointestinal radiation oncologist Emma Holliday, M.D., who debunked three of the most common myths she hears about anal cancer.
1. Myth: Anal cancer is the same as colorectal cancer.
Truth: Anal cancer is different from colorectal cancer. These diseases are defined by the location of the tumor and the type of cancer cell that makes up the tumor. In the case of anal cancer, the tumor is located in the anus and anal canal.
Some patients know they have anal cancer but still tell friends and family they are being treated for colorectal cancer. This is because many people feel uncomfortable talking about the anus.
“We need to do a better job of removing the discomfort and stigma associated with talking about the anus, so doctors can do a better job of explaining to patients exactly what kind of cancer they have,” says Holliday. “This will also help patients feel empowered to share their experience with others if they choose to do so.”
2. Myth: Only promiscuous people or people who have receptive anal intercourse get anal cancer.
Truth: The human papillomavirus (HPV) is the biggest risk factor for anal cancer, and it is very common. Eight out of 10 people in the United States will be infected by this virus in their lifetime. It can be transmitted through any intimate skin-to-skin contact. Most people’s immune system gets rid of the virus before it causes any problems. But for some people, the virus will set off changes in cells that could grow into cancer.
Having anal cancer, or another HPV-related cancer, does not mean you are actively infected with HPV. It also doesn’t mean you caught the virus recently. It usually takes decades between HPV infection and the cell changes that turn into cancer. If you’re eligible, you can get the HPV vaccine to help prevent anal cancer and five other types of cancer.
Having anal sex, especially as the receiving partner, has long been listed as a risk factor for anal cancer. However, it doesn’t mean you have to have had anal sex to get anal cancer.
“I think this misconception makes patients reluctant to speak openly about their diagnosis,” says Holliday. “The anus is just another body part! We should be able to talk about it as if it were the colon, prostate or elbow.”
3. Myth: Treatment for anal cancer means I’ll need a colostomy bag.
Truth: The most common type of anal cancer is squamous cell carcinoma, which forms in the cells that line the anus. Anal squamous cell carcinoma is usually successfully treated with radiation therapy and chemotherapy. Most patients do not need surgery for this cancer and do not need a colostomy bag.
If you’re an MD Anderson patient struggling to navigate your anal cancer diagnosis, you can connect with a social work counselor who can provide support and resources to help you cope with your feelings.
Request an appointment at MD Anderson online or by calling 1-855-942-1358.

We need to do a better job of removing the discomfort and stigma associated with talking about the anus.
Emma Holliday
Physician